Journal of Infectious Diseases & Preventive Medicine

Journal of Infectious Diseases & Preventive Medicine
Open Access

ISSN: 2329-8731

+44 1300 500008

Research Article - (2017) Volume 5, Issue 2

Whole Genome Sequencing for Detection of Zoonotic Tuberculosis in Queretaro, Mexico

Claudia Angelica Perea Razo1, Feliciano Milian Suazo2, Isabel Barcenas Reyes1, Susana Sosa Gallegos2, Elba Rodriguez Hernandez3, Susana Flores Villalva3 and Germinal Jorge Canto Alarcon2*
1Doctorado en Ciencias Biologicas, Universidad Autonoma de Queretaro, Queretaro, Mexico
2Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro, Queretaro, Mexico
3CENID, Fisiologia y Mejoramiento Animal, INIFAP, Colon, Queretaro, Mexico
*Corresponding Author: Germinal Jorge Canto Alarcon, Facultad de Ciencias Naturales, Universidad Autonoma de Queretaro, Queretaro, Mexico, Tel: 52(442)1921200 Exn. 5347 Email:

Abstract

A total of 2,736 samples, sputum, urine, and other fluids, collected from 1,154 tuberculosis suspicious patients in Queretaro, Mexico were included in the study. Acid-fast staining and culture in selective mediums, Stonebrink and Lowenstein-Jensen, were performed in all samples. Genotyping of isolates was performed by spoligotyping and single nucleotide polimorfism (SNP) whole genome sequencing. Mycobacterium bovis spoligotypes and SNP-types obtained were compared to those of cattle found in a database. Twenty-one (1.8%) isolates of Mycobacterium were obtained by culture, all from sputum; two (13%) were identified as M. bovis by spoligotyping, SB0673 and SB0971, which are frequently found in cattle in Mexico. From the isolates´ total, 15 were whole genome sequenced, confirming two as M. bovis. The SNP patterns of the two M. bovis isolates from human were similar to those found in cattle in different parts of Mexico.

<

Keywords: M. bovis; Tuberculosis; Spoligotyping; Molecular epidemiology; Queretaro

Introduction

Tuberculosis (TB) is a disease that affects both humans and animals. Humans are predominantly infected by Mycobacterium tuberculosis whereas animals by M. bovis; however, both are susceptible to both species, with no significant clinical, radiological or pathological differences [1]. Mycobacterium tuberculosis and M. bovis are 99.9% similar at the nucleotide and 16S rRNA sequences, virtually identical [2-4]. M. bovis has usually neglected as an important pathogen in human tuberculosis; nevertheless, different studies in different populations have shown that M. bovis has an important role in human tuberculosis [5-9]. In past decades, retrospective studies on stored samples reported that TB due to M. bovis is between 8 and 10% [5-7]. Recent studies in Mexico, in a dairy zone with high prevalence of the disease in cattle (17%), a prevalence of 7% was found in samples from symptomatic patients [8]. More recently, in San Diego, M. bovis was found in 45% of tuberculosis cases in children, 6% in adults, most in patients with Hispanic background [9]. From 1995 to 2009, at the Occidental Medical Center of Guadalajara, Jalisco, Mexico, from 124 cases, 35 (28%) were due to M. bovis; 26 extra-pulmonary [10]. A study performed at the Siglo XXI Hospital in Mexico City in samples from 2000 to 2007, reported 22.3% of cases due to M. bovis [11].

In humans, M. bovis is an opportunistic pathogen that takes advantage of vulnerable populations, such as those with acquired immunodeficiency syndrome (AIDS) [12-14], diabetes mellitus, the presence of lymphomas, leukemia, chronic renal insufficiency, immunosuppressant treatments, disorders associated to gastrectomy and jejunoileal surgery, malnutrition, overpopulation, smoking and drug addiction [15-21]. The presence of M. bovis in human cases is relevant since it is resistant to pyrazinamide, a first-line antibiotic used in the treatment of tuberculosis.

In Mexico, the prevalence of tuberculosis in cattle has been reported to be less than 0.5% in 25 regions or states, classified by APHIS-USDA as low prevalence [22]. Twelve states are in the eradication phase, with prevalence lower than 2%, and 21 states are in the control phase,with prevalence higher than 2% or unknown. In general, it has been estimated that the prevalence of tuberculosis in dairy cattle in Mexico is ≈16%. Actual federal regulation does not make pasteurization of milk mandatory, which is why there is still risk of infection with M. bovis in humans through the consumption of non-pasteurized dairy products. Thus, the objective of the present study was to determine the proportion of cases of tuberculosis caused by M. bovis in patients from the Mexican Social Security Institute (IMSS) in the City of Queretaro; as well as to compare the genotypes from people and those obtained from cattle.

Materials and Methods

Biological samples

Samples from sputum, urine and other tissues were collected from TB suspicious patients, three in consecutive days at the Mexican Social Security Institute (IMSS) of the City of Queretaro, Mexico from October 2013 to July 2014. Isolation of Mycobacterium was performed by culturing in Stonebrink and Lowenstein-Jensen mediums [23]. Isolates were genotyped by spoligotyping [24] and whole genome sequencing for the identification of single nucleotide polymorphisms (SNP).

Samples from cattle

Suspicious lesions were obtained from cattle at slaughterhouses in different parts of Mexico. These samples were decontaminated by the Petroff method and inoculated on to Stonebrink medium for the isolation of M. bovis. All of the resulting isolates were genotyped by spoligotyping and 200 of them were whole genome sequenced.

Whole genome sequencing and phylogenetic analysis

Whole genome sequencing was performed at the National Veterinary Services Laboratory of APHIS-USDA (NVSL-APHIS-USDA) in Ames, Iowa, USA, according to their own protocols [25]. Isolates were sequenced using a MiSeq (Illumina, San Diego, CA) and the Nextera XT library preparation kit (Illumina, San Diego, CA). Using the NVSL in-house pipeline, the sequences were aligned and compared to the reference genome AF2122/97 (NCBI accession number NC_0002945) for SNP calling. Only informative and validated SNPs were used to construct maximum likelihood phylogenetic trees using RAxML.

Results

A total of 2,736 samples were analyzed from 1,154 tuberculosis suspicious patients. Two-thousand two-hundred thirty six (83%) of the samples were sputum, 434 (16%) urine and 37 (1%) from other tissues/ fluids: gastric juice, cerebrospinal fluid, pleural fluid and ascitic fluid, among others. According to the sputum quality, some were classified as saliva, 329 (14.5%), and 1936 (85.5%) as phlegm. Most patients were from out-patient consulting (55%), 22% from hospitalization and 23% had no information, 46% were women and 43% men. Eleven percent had no information about gender. Fifty percent were younger than 30 years, 23% were between 31 and 60 years, and 27% were older than 60 years.

From the 1,154 patients in the study, a total of 21 (1.8%) isolates were obtained by culture and identified as Mycobacterium, all of them from sputum. As sputum is obtained from the lungs, this confirms this organ as the site of tuberculosis infection, which indicates pulmonary disease. From these, 17 were also positive to AFB stain (Table 1). Six of the positive patients were women (29%) and seven men (33%). It was not possible to obtain information for the other 8 (38%) patients. According to age, 5 (24%) were between 31 and 60 years old, and 4 (19%) were older than 60 years old; no information could be obtained from the rest. Positive cases corresponded mainly to hospitalized patients (57%).

  CULTURE  
    Positive Negative Total
AFB Positive 16 1 17
  Negative 4 0 4
  Total 20 1 21
    SENSITIVITY 80%  

Table 1: Diagnostic results for AFB and isolation tests of tuberculosis suspicious samples of people in Queretaro, Mexico from October 2013 to July 2014.

Real-time PCR was performed for the 21 isolates, 2 (13%) were identified as M. bovis. These isolates were also whole genome sequenced, and 13 (87%) were identified as M. tuberculosis. Considering the total number of isolates (n=21), 9.5% were M. bovis. Suprisingly, one isolate, 13-1206497FM, was identified as Mycobacterium terrae, a species that does not belong to the MTBC complex (Figure 1).

ancient-diseases-preventive-remedies-Species-Mycobacterium

Figure 1: Species of Mycobacterium involved in cases of human tuberculosis in suspicious patients from Queretaro, Mexico, October 2013 to July 2014.

The spoligotype pattern of one of the M. bovis isolates was identified as SB0673, which is one of the most frequent spoligotypes in cattle in Mexico. This spoligotype has been identified previously in other cases of human tuberculosis, in Mexico [26], as well as in the United States in patients of Mexican origin [27,28]. The spoligotype from the second isolate was SB0971, which is the fifth most common spoligotype in Mexico, and it has also been identified in humans from previous studies in Mexico, as well as in the United States in patients of Mexican origin.

Using the SNP patterns obtained for the M. bovis isolates, both from human origin (n=2) and cattle origin (n=200), alignments were performed and phylogenetic trees were constructed in order to find genetic relationship between them. The same was performed using only isolates from cattle in Mexico. The SNP patterns for the two isolates of human origin, 13-1212317FM and 14-805568FM, were almost identical to those from cattle of the region of Queretaro (97-2166, 97-2398, 97-2167; 97-1525 and 97-2453, respectively) (Figure 2). These results confirm that M. bovis plays an important role in human tuberculosis in Mexico.

ancient-diseases-preventive-remedies-phylogenetic-trees

Figure 2a: Maximum likelihood SNP-based phylogenetic trees presenting genetic relationships between SNP-genotypes of M. bovis isolates from cattle and humans-13-1212317FM. Red arrows show how the human isolates lies within a clade of isolates of bovine origin.

ancient-diseases-preventive-remedies-genetic-relationships

Figure 2b: Maximum likelihood SNP-based phylogenetic trees presenting genetic relationships between SNP-genotypes of M. bovis isolates from cattle and humans-14-805568FM. Red arrows show how the human isolates lies within a clade of isolates of bovine origin.

Discussion

The objective of this study was to estimate the proportion of human cases of tuberculosis that is caused by M. bovis in patients suspected of having the disease in the City of Queretaro, Mexico, and to compare the M. bovis spoligotypes and SNP-types from humans to those found in cattle. The proportion of cases of human tuberculosis due to M. bovis was 9%, which is close to the 4.5% reported by Laniado-Laborin et al. [29], and, but lower than the 28% reported by Portillo-Gomez and Sosa-Iglesias [10], and the 31.6% by Toledo-Orduña et al. [30]. All of these figures, however, are higher than the 3.1% reported by WHO worldwide [31]. Recent studies in other parts of the world have reported numbers such as 6.9% in Uganda [32], 5% in Nigeria [33], 0.5% in Taiwan [34] and between 0 and 2.5% in ten Latin American countries [35]. The difference across these proportions may be due to the fact that cases reported are mainly from urban areas or industrialized countries, whilst undeveloped countries rarely or sporadically have access to the resources needed to perform differential analysis of the causal agent.

It is surprising that from 2,736 samples, only 21 were positive to AFB and isolation. This suggests that the quality of the samples turned into the laboratories is not useful for diagnosis; training courses for medical staff dealing with patients could be appropriate. Better quality of samples reduces the amount of resources used in diagnosis. This is important given the low sensitivity of the AFB stain, which overlooks about 20% of the cases (Table 1); which is confirmed in our study.

Through molecular and phylogenetic analysis the genetic and epidemiological relationship between M. bovis strains obtained from humans and cattle (Figure 2) in the same geographic region could be established. Isolates 13-1212317FM and 14-805568FM obtained from humans had the same molecular patterns as those obtained from cattle, which confirms that transmission of M. bovis between these populations is occurring.

Through molecular and phylogenetic analysis the genetic and epidemiological relationship between M. bovis strains obtained from humans and cattle (Figure 2) in the same geographic region could be established. Isolates 13-1212317FM and 14-805568FM obtained from humans had the same molecular patterns as those obtained from cattle, which confirms that transmission of M. bovis between these populations is occurring. Interestingly, both isolates were obtained from sputum, which suggests respiratory as the most probable route of transmission, making the lungs the site of infection; challenging the common belief that M. bovis causes only extra-pulmonary infections. This is also important because M. bovis has been mostly associated with the digestive route of transmission, with lesions in mesenteric lymph nodes. From our results, it can be inferred that transmission occurs directly from cattle to human by inhalation of infected aerosols, causing pulmonary tuberculosis. Unfortunately, it was not possible to obtain information about patients´ occupation.

A weakness of this study is the lack of epidemiological information of patients. The reason for this is because we were not successful in obtaining this information from IMSS authorities in spite of our constant requests for it.

Conclusion

The proportion of cases of tuberculosis by M. bovis in suspected patients in Queretaro, Mexico was 9%. Spoligotypes SB0673 and SB0971 from the human isolates are identical to spoligotypes obtained from cattle across Mexico in general, but particularly from Queretaro. SNP patterns from the whole genome analysis of the M. bovis strains from humans were very similar to those identified in cattle from various states of Mexico, including Queretaro. M. bovis, the causal agent of tuberculosis in cattle has a very important role in human cases of TB.

Acknowledgments

We thank the Mexican Social Security Institute (IMSS) for their cooperation in providing the clinical samples used in this study. A special thanks to NVSL-APHIS-USDA, particularly Suelee Robbe- Austerman and Tod Stuber, for the training and support provided, their collaboration is a very important part of this work. Also, this project was financed by the Rectory Fund for Special Projects (FOPER 2014) of the Autonomous University of Queretaro.

Conflict of Interests

The authors declare that there is no conflict of interest regarding the publication of this manuscript.

References

  1. Grange JM (2001) Mycobacterium bovis infection in human beings. Tuberculosis 81: 71-77.
  2. Bóddinghaus B, Rogalí I, Flohr T, Blúcker H, BtittgerEC (1990) Detection and identification of mycobacteriabyamplification of rRNA. J ClinMicrobiol 28: 1751-1759.
  3. Sreevatsan S, Pan X, StockbauerKE, Connell ND, KreiswirthBN, et al. (1997) Restrictedstructural gene polymorphism in the Mycobacterium tuberculosiscomplexindicatesevolutionarilyrecent global dissemination. ProcNatlAcadSci 94: 9869-9874.
  4. HuardRC, Fabre M, de Haas P, LazzariniLC, van Soolingen D, et al. (2006) Novel geneticpolymorphismsthatfurtherdelineate the phylogeny of the Mycobacterium tuberculosis complex. J Bacteriol 188: 4271-4287.
  5. Cosivi O, GrangeJM, DabornCJ, Raviglione MC, Fujikura T, et al. (1998) Zoonotic tuberculosis duetoMycobacteriumbovis in developingcountries. EmergInfectDis 4: 59-70.
  6. Thoen CO, SteeleJH, Gilsdorf M (2006) MycobacteriumbovisInfection in Animals and Humans, 2ndedition. Ed. EmergInfectDis 12: 1306.
  7. De Kantor I, Ritacco V (2006) An update on bovine tuberculosis programs in Latin American and Caribbeancountries. VetMicrobiol 112: 111-118.
  8. Pérez-Guerrero L, Milían-Suazo F, Arriaga-Díaz C, Romero-Torres C, Escartín-Chávez M (2008) Epidemiología molecular de las tuberculosis bovina y humana en una zona endémica de Querétaro, México. Salud PúbMéx 50: 286-291.
  9. RodwellTC, Moore M, Moser KS, Brodine SK, Strathdee S (2008) Tuberculosis from Mycobacterium bovis in Binational Communities, United States. Emerg Infect Dis 14: 909-916.
  10. Portillo-Gómez L, Sosa-Iglesias EG (2011) Molecular identification of Mycobacterium bovis and the importance of zoonotic tuberculosis in Mexican patients. Int J Tuberc Lung Dis 15: 1409-1414.
  11. Torres-González P, Soberanis-Ramos O, Martinez-Gamboa A, Chavez-Mazari B, Barrios-Herrera MT, et al. (2013) Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoSNegl Trop Dis 7: e2177.
  12. Llaca-Díaz JM, Flores-Aréchiga A, Martínez-Guerra MG, Cantú-Martínez PC (2003) La baciloscopía y el cultivo en el diagnóstico de la tuberculosis extrapulmonar. Rev Salud Pub Nut 4.
  13. Shen Y, Shen L, Sehgal P, Huang D, Qiu L, et al. (2004) Clinicallatency and reactivation of AIDS-relatedmycobacterialinfections. J Virol 78: 14023-14032.
  14. Valerga M, Viola C, Thwaites A, Bases O, Ambroggi M, et al. (2005) Tuberculosis por Mycobacteriumbovis en una mujer con SIDA. RevArgMicrobiol 37: 96-98. 
  15. Moda G, Daborn CJ, Grange JM, Cosivi O (1996) The zoonotic importance of Mycobacterium bovis. Tuberc Lung Dis 77: 103-108.
  16. Milián-Suazo F, Salman MD, Black WC, Triantis JM, Ramírez C, et al. (2000) Molecular epidemiologic analysis of Mycobacterium bovis isolates from México. Am J Vet Res 61: 90-95.
  17. Caminero JA (2003) Guía de la Tuberculosis para Médicos Especialistas. Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias (UICTER). París, Francia.
  18. Araujo Z, Acosta M, Escobar H, Baños R, Fernández de Larrea C, et al. (2008) Respuesta inmunitaria en tuberculosis y el papel de los antígenos de secreción de Mycobacterium tuberculosis en la protección, patología y diagnóstico: Revisión. Investigación Clínica 49: 411-441.
  19. Lienhardt C, Fielding K, SillahJS, Bah B, Gustafson P, et al. (2005) Investigation of the riskfactorsfor tuberculosis: a case-control study in threecountries in West Africa. Int J Epidemiol 34: 914-923.
  20. ChayakaJM (2007) Optimizing the diagnosis of Pulmonary Tuberculosis.  EAMJ 3: 453-454.
  21. Gasana M, Vandebriel G, Kabanda G, Mugabo J, Tsiouris S, et al. (2007) Tuberculosis in Rwanda: challengestoreaching the targets. WHO 85: 325-420.
  22. Servicio Nacional de Sanidad, Inocuidad y Calidad Agroalimentaria (2015) Tuberculosis Bovina: Situación actual.
  23. Blancarte ML,  AnzaldoJG, Balandrano SS (1992) Manual de técnicas y procedimientos de laboratorios en tuberculosis. Secretaría de Salud, México DF. Publicación Técnica 20: 75.
  24. Kamerbeek J, Schouls L, Kolk A, Van Soolingen D, Kuijper A, et al. (1997) Simultaneousdetection and straindifferentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J ClinMicrobiol 35: 907-914.
  25. Glaser L, Carstensen M, Shaw S, Robbe-Austerman S, Wunshmann A, et al. (2016) Descriptiveepidemiology and wholegenomesequencinganalysisfor an outbreak of bovine tuberculosis in beefcattle and white-taileddeer in Northwestern Minnesota. PLOS ONE 11: e0145735.
  26. Milián-Suazo F, Pérez-Guerrero L, Arriaga-Díaz C, Escartín-Chávez M (2010) Molecular epidemiology of human cases of tuberculosis by Mycobacterium bovis in Mexico. Prev Vet Med 97: 37-44.
  27. RodwellTC, KapasiAJ, Moore M, Milián-Suazo F, Harrise B, et al. (2010) Tracing the origins of Mycobacterium bovis tuberculosis in humans in the United States to cattle in Mexico using spoligotyping. Int J Infect Dis 14S: e129–e135.
  28. Centers for Disease Control and Prevention (2005) Human tuberculosis caused by Mycobacterium bovis: New York City 2001-2004. MMMWR 54: 605-608.
  29. Laniado-Laborín R, Muñiz-Salazar R, García-Ortíz RA, Vargas-Ojeda AD, Villa-Rosas C, et al. (2014) Molecular characerization of Mycobacteriumbovis isolates from patients with tuberculosis in Baja California, Mexico. Infect Genet Evol 27: 1-5.
  30. Toledo-Ordoñez P, Milián-Suazo F, Santillan-Flores MA, Ramírez-Casillas CI (1999) Aislamiento e identificación de Mycobacteriumbovis a partir de muestras de expectoración de pacientes humanos con problemas respiratorios crónicos. VetMex 30: 227-229.
  31. WorldHealthOrganization (2009) Global tuberculosis control report: Epidemiology, Strategy, Financing.
  32. Oloya J, Opuda-Asibo J, Kazwala R, Demelash AB, Skjerve E, et al. (2008) Mycobacteriacausing human cervical lymphadenitis in pastoral communities in the Karamojaregion of Uganda. EpidemiolInfect 136: 636-643.
  33. Cadmus S, Palmer S, Okker M, Dale J, Gover K, et al. (2006) Molecular analysis of human and bovinetuberclebacillifrom a local setting in Nigeria. J ClinMicrobiol 44: 29-34.
  34. Jou R, HuanWL, ChiangCY (2008) Human tuberculosis causedbyMycobacteriumbovis, Taiwan. EmergInfectDis 14: 515-517.
  35. De Kantor I, Ambroggi M, Poggi S, Morcillo N, Da Silva-Telles MA, et al. (2008) Human Mycobacterium bovis infection in ten Latin American countries. Vet Microbiol 88: 358-365.
Citation: Perea Razo CA, Suazo FM, Reyes IB, Gallegos SS, Hernandez ER, et al. (2017) Whole Genome Sequencing for Detection of Zoonotic Tuberculosis in Queretaro, Mexico. J Infect Dis Preve Med 5: 158.

Copyright: © 2017 Perea Razo CA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top